SCHEMBL1103000

SCHEMBL1103000

c1ccc2c(-c3ccc(-c4c5ccccc5c(-c5ccc(-c6cccc7ccccc67)cc5)c5ncccc45)cc3)cccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
ENPP1 P22413 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ENPP3 O14638 1/20 0.42
GAA P10253 1/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
TNF P01375 1/20 0.41
CCR1 P32246 3/20 0.41
CCR8 P51685 3/20 0.41
CYP3A4 P08684 2/20 0.41
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
GMNN O75496 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102981 0.97 TNF (0.46) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103198 0.95 KDM4E (0.41) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103133 0.92 PIM1 (0.40) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103117 0.91 KDM4E (0.40) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103095 0.91 KDM4E (0.40) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103087 0.91 KDM4E (0.42) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103102 0.90 KDM4E (0.40) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1102931 0.88 CCR1 (0.41) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103006 0.88 TNF (0.41) KDM4EMAPTENPP1ALDH1A1HPGD
SCHEMBL1103184 0.88 KDM4E (0.40) KDM4EMAPTENPP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 KDM4E 3367/4885MAPT 3162/4885ENPP1 2661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.